Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 361-366

  Shidara, Kumi ^a   Inoue, Eisuke ^a   Hoshi, Daisuke ^a   Sato, Eri ^a   Nakajima, Ayako ^a   Momohara, Shigeki ^a   Taniguchi, Atsuo ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti CCP antibody; Functional disability; Methotrexate; Prognosis; Rheumatoid arthritis

Indexed keywords

BUCILLAMINE; CORTICOSTEROID DERIVATIVE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PREDNISOLONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG USE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 84857037521     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1671-3     Document Type: Article

References (30)

1. AN Lee CE Beck M Hall 2008 Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review Clin Lab Sci 21 15 18 18335856 1:CAS:528:DC%2BD1cXosVKrt7o%3D
2. B Vander Cruyssen I Peene T Cantaert, et al. 2005 Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor Autoimmun Rev 4 468 474 16137613 10.1016/j.autrev.2005.04.018 1:CAS:528:DC%2BD2MXhtFeksb%2FE (Pubitemid 41219326)
3. S Nijenhuis AJ Zendman ER Vossenaar, et al. 2004 Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker Clin Chim Acta 350 17 34 15530456 10.1016/j.cccn.2004.07.016 1:CAS:528:DC%2BD2cXpsVKnu70%3D (Pubitemid 39458243)
4. T Möttönen L Paimela M Leirisalo-Repo, et al. 1998 Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy Ann Rheum Dis 57 533 539 9849312 10.1136/ard.57.9.533 (Pubitemid 28474060)
5. H Guler AD Turhanoglu B Ozer, et al. 2008 The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis Scand J Rheumatol 37 337 342 18609264 10.1080/03009740801998812 1:CAS:528:DC%2BD1cXhtFOrtb7L
6. B Combe JF Eliaou JP Daurès, et al. 1995 Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage Br J Rheumatol 34 529 534 7633794 10.1093/rheumatology/34.6.529 1:STN:280:DyaK2MzmtVCitw%3D%3D
7. M Sebbag M Simon C Vincent, et al. 1995 The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies J Clin Invest 95 2672 2679 7539459 10.1172/JCI117969 1:CAS:528:DyaK2MXmtV2qsL8%3D
8. BJ Young RK Mallya RD Leslie, et al. 1979 Anti-keratin antibodies in rheumatoid arthritis Br Med J 2 97 99 111762 10.1136/bmj.2.6182.97 1:CAS:528:DyaL3cXhvF2msA%3D%3D (Pubitemid 9219480)
9. SQ Gan OW McBride WW Idler, et al. 1990 Organization, structure, and polymorphisms of the human profilaggrin gene Biochemistry 29 9432 9440 2248957 10.1021/bi00492a018 1:CAS:528:DyaK3cXlsVKnu78%3D (Pubitemid 20329081)
10. GA Schellekens BA de Jong FH van den Hoogen, et al. 1998 Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 273 281 9421490 10.1172/JCI1316 1:CAS:528:DyaK1cXjtFSjsg%3D%3D (Pubitemid 28058927)
11. E Girbal-Neuhauser JJ Durieux M Arnaud, et al. 1999 The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues J Immunol 162 585 594 9886436 1:CAS:528: DyaK1MXjtlahsQ%3D%3D (Pubitemid 29018970)
12. GA Schellekens H Visser BA de Jong, et al. 2000 The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 43 155 163 10643712 10.1002/1529-0131(200001)43:1<155::AID- ANR20>3.0.CO;2-3 1:CAS:528:DC%2BD3cXns1ygtg%3D%3D (Pubitemid 30368225)
13. O Meyer C Labarre M Dougados, et al. 2003 Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann Rheum Dis 62 120 126 12525380 10.1136/ard.62.2.120 1:CAS:528:DC%2BD3sXhtlSiu7Y%3D (Pubitemid 36135386)
14. I Vallbracht J Rieber M Oppermann, et al. 2004 Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis Ann Rheum Dis 63 1079 1084 15308516 10.1136/ard.2003.019877 1:CAS:528:DC%2BD2cXnvFWkt70%3D (Pubitemid 39120358)
15. SK Kim SH Park IH Shin, et al. 2008 Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis J Rheumatol 35 995 1001 18464311 10.3899/jrheum.080114
16. N del Val del Amo R Ibanez Bosch C Fito Manteca, et al. 2006 Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness Clin Exp Rheumatol 24 281 286 (Pubitemid 44151147)
17. E Tanaka A Mannalithara E Inoue, et al. 2008 Efficient management of rheumatoid arthritis significantly reduces long-term functional disability Ann Rheum Dis 67 1153 1158 17971459 10.1136/ard.2007.072751 1:STN:280: DC%2BD1cvksVWmtA%3D%3D
18. H Yamanaka E Inoue G Singh, et al. 2007 Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan Mod Rheumatol 17 283 289 17694260 10.1007/s10165-007-0587-6 (Pubitemid 47263818)
19. N Iikuni E Sato M Hoshi, et al. 2009 The influence of sex on patients with rheumatoid arthritis in a large observational cohort J Rheumatol 36 508 511 19208610 10.3899/jrheum.080724
20. S Momohara E Inoue K Ikari, et al. 2008 Risk factors for wrist surgery in rheumatoid arthritis Clin Rheumatol 27 1387 1391 18500434 10.1007/s10067-008- 0928-7
21. FC Arnett SM Edworthy DA Bloch, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280: DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
22. Y Matsuda G Singh H Yamanaka, et al. 2003 Validation of a Japanese version of the stanford health assessment questionnaire in 3,763 patients with rheumatoid arthritis Arthritis Rheum 49 784 788 14673964 10.1002/art.11465 (Pubitemid 37523630)
23. ML Prevoo MA van 't Hof HH Kuper, et al. 1995 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48 7818570 10.1002/art.1780380107 1:STN:280:DyaK2M7hvVeqtA%3D%3D
24. N Inanc E Dalkilic S Kamali, et al. 2007 Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis Clin Rheumatol 26 17 23 16538391 10.1007/s10067-006-0214-5 1:STN:280:DC%2BD2s%2FoslGlug%3D%3D (Pubitemid 46020016)
25. K Forslind M Ahlmén K Eberhardt, et al. 2004 Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann Rheum Dis 63 1090 1095 15308518 10.1136/ard.2003.014233 1:CAS:528:DC%2BD2cXnvFWkt7k%3D (Pubitemid 39120360)
26. A Kastbom G Strandberg A Lindroos, et al. 2004 Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) Ann Rheum Dis 63 1085 1089 15308517 10.1136/ard.2003. 016808 1:CAS:528:DC%2BD2cXnvFWkt7s%3D (Pubitemid 39120359)
27. VP Nell KP Machold TA Stamm, et al. 2005 Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis Ann Rheum Dis 64 1731 1736 15878904 10.1136/ard.2005.035691 1:CAS:528:DC%2BD2MXhtlWgs7jF (Pubitemid 41667147)
28. DL Scott DP Symmons BL Coulton, et al. 1987 Long-term outcome of treating rheumatoid arthritis: results after 20 years Lancet 1 1108 1111 2883443 10.1016/S0140-6736(87)91672-2 1:STN:280:DyaL2s3gtVCktA%3D%3D
29. AH van der Helm-van Mil KN Verpoort FC Breedveld, et al. 2005 Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis Arthritis Res Ther 7 R949 R958 16207336 10.1186/ar1767
30. EJ Kroot BA de Jong MA van Leeuwen, et al. 2000 The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum 43 1831 1835 10943873 10.1002/1529- 0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 1:CAS:528:DC%2BD3cXmtFKju7w%3D (Pubitemid 30640938)